Lv1
10 积分 2026-02-04 加入
Oral semaglutide for weight loss and liver fibrosis in overweight and obesity: A randomized controlled trial
7小时前
待确认
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
7小时前
已完结
Clinical Trial: Semaglutide Versus Placebo in NIT-Assessed MASH-A Multicenter Randomised Placebo-Controlled Trial (SAMARA)
7小时前
已完结
Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled study
7小时前
已完结
Recent advances in the treatment of IBD: Targets, mechanisms and related therapies
6个月前
已完结
皖公网安备34019202002308
